Complement-Mediated Thrombotic Microangiopathy with 10 Years of Stable Renal Function After a Year-Long Treatment with Eculizumab with Coincidental Polycystic Kidney Disease

Mehul P. Dixit; Lucy Woolverton; Sabahat Afshan

doi:10.12659/AJCR.938367

21 January 2023 : Case report USA

Complement-Mediated Thrombotic Microangiopathy with 10 Years of Stable Renal Function After a Year-Long Treatment with Eculizumab with Coincidental Polycystic Kidney Disease

Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Rare disease

Mehul P. Dixit^1ACDEF*, Lucy Woolverton^1ABEF, Sabahat Afshan^1EFG

DOI: 10.12659/AJCR.938367

Am J Case Rep 2023; 24:e938367

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 2. Renal ultrasound of left kidney demonstrating multiple cysts. The renal ultrasound was performed 10 years after the original cTMA diagnosis as part of a surveillance followup. cTMA – complement-mediated thrombotic microangiopathy.

Back to the Article

Complement-Mediated Thrombotic Microangiopathy with 10 Years of Stable Renal Function After a Year-Long Treatment with Eculizumab with Coincidental Polycystic Kidney Disease

Your Privacy